UNSPSC 51272407: Methoxyflurane

This classification denotes an anesthetic agent with the molecular formula C3H4Cl2F2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 30905R8O7B, chemically known as 2,2-dichloro-1,1-difluoroethyl methyl ether but generally known as methoxyflurane, which bears US NIH Compound Identifier 4116. European Medicines Agency schedules Methoxyflurane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08858MIG.

UNSPSC 51272407 Methoxyflurane is a Commodity code that encompasses pharmaceutical products and emergency medical supplies procured by state and local health agencies, though recent state and local opportunities tagged to this code show mixed alignment with the code's nominal scope. State and local purchasing under this code spans pharmaceutical distribution contracts, emergency response supplies, and healthcare system procurement. The mix of issuing bodies includes county health departments (Seminole County, Florida), state health and human services agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving state, county, and municipal health systems across Oregon and Minnesota). Scope of work includes generic multi-source pharmaceuticals and over-the-counter products supplied through authorized wholesalers with specific National Drug Code requirements, emergency medical countermeasures such as naloxone, and pharmacy benefit program contracting to manage prescription fulfillment and cost optimization.

Recent activity concentrates in the Southeast and Upper Midwest, with posted opportunities in Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building, with a bid deadline of July 26, 2023. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 on January 20, 2026, seeking manufacturers of generic pharmaceuticals and OTC products for multi-state distribution through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co.), with proposals due March 26, 2026 and contract effectiveness set for July 1, 2026. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, as preliminary market research into direct-to-manufacturer prescription programs for pharmacy benefit contracting, with response due April 3, 2026. Vendors participating in these procurements must meet FDA compliance, cGMP certification, Drug Supply Chain Security Act adherence, and insurance requirements including workers' compensation and professional liability coverage.